JPWO2023249087A1 - - Google Patents
Info
- Publication number
- JPWO2023249087A1 JPWO2023249087A1 JP2024529079A JP2024529079A JPWO2023249087A1 JP WO2023249087 A1 JPWO2023249087 A1 JP WO2023249087A1 JP 2024529079 A JP2024529079 A JP 2024529079A JP 2024529079 A JP2024529079 A JP 2024529079A JP WO2023249087 A1 JPWO2023249087 A1 JP WO2023249087A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022101870 | 2022-06-24 | ||
| PCT/JP2023/023170 WO2023249087A1 (ja) | 2022-06-24 | 2023-06-22 | 医薬組成物およびその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023249087A1 true JPWO2023249087A1 (https=) | 2023-12-28 |
Family
ID=89380027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529079A Pending JPWO2023249087A1 (https=) | 2022-06-24 | 2023-06-22 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250367120A1 (https=) |
| EP (1) | EP4545069A1 (https=) |
| JP (1) | JPWO2023249087A1 (https=) |
| AU (1) | AU2023288296A1 (https=) |
| WO (1) | WO2023249087A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117859843B (zh) * | 2024-03-13 | 2024-06-04 | 潍坊柯能生物科技有限公司 | 一种蛋鸡用复合胆汁酸预混料的生产方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008500339A (ja) * | 2004-05-24 | 2008-01-10 | ザ プロクター アンド ギャンブル カンパニー | キレート剤を含有するビスホスホネートの腸溶性で固形の経口剤形 |
| JP2008522989A (ja) * | 2004-12-10 | 2008-07-03 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 核酸包含粘膜接着性作用物質を含有する多粒子投与形、および前記投与形を生成する方法 |
| JP2011519915A (ja) * | 2008-05-05 | 2011-07-14 | オラムド エルティーディー． | エクセナチドの経口投与用の方法および組成物 |
| JP2016523250A (ja) * | 2013-06-17 | 2016-08-08 | ラプター ファーマシューティカルズ インコーポレイテッド | 遅延放出システアミンビーズ処方、ならびにその作製方法および使用方法 |
| JP2018505172A (ja) * | 2015-01-29 | 2018-02-22 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１アゴニスト及び腸溶コーティングを含む錠剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102272671B1 (ko) | 2013-05-02 | 2021-07-06 | 노보 노르디스크 에이/에스 | Glp-1 화합물의 경구 투여 |
| JP6409937B1 (ja) | 2017-10-13 | 2018-10-24 | 三生医薬株式会社 | 造粒方法及び造粒装置 |
-
2023
- 2023-06-22 WO PCT/JP2023/023170 patent/WO2023249087A1/ja not_active Ceased
- 2023-06-22 EP EP23827269.4A patent/EP4545069A1/en active Pending
- 2023-06-22 US US18/876,738 patent/US20250367120A1/en active Pending
- 2023-06-22 AU AU2023288296A patent/AU2023288296A1/en active Pending
- 2023-06-22 JP JP2024529079A patent/JPWO2023249087A1/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008500339A (ja) * | 2004-05-24 | 2008-01-10 | ザ プロクター アンド ギャンブル カンパニー | キレート剤を含有するビスホスホネートの腸溶性で固形の経口剤形 |
| JP2008522989A (ja) * | 2004-12-10 | 2008-07-03 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 核酸包含粘膜接着性作用物質を含有する多粒子投与形、および前記投与形を生成する方法 |
| JP2011519915A (ja) * | 2008-05-05 | 2011-07-14 | オラムド エルティーディー． | エクセナチドの経口投与用の方法および組成物 |
| JP2016523250A (ja) * | 2013-06-17 | 2016-08-08 | ラプター ファーマシューティカルズ インコーポレイテッド | 遅延放出システアミンビーズ処方、ならびにその作製方法および使用方法 |
| JP2018505172A (ja) * | 2015-01-29 | 2018-02-22 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１アゴニスト及び腸溶コーティングを含む錠剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20250367120A1 (en) | 2025-12-04 |
| WO2023249087A1 (ja) | 2023-12-28 |
| AU2023288296A1 (en) | 2025-01-09 |
| EP4545069A1 (en) | 2025-04-30 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241018 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251021 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251216 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260331 |